Cyclophilin A: a novel biomarker for cardiovascular disease in patients with type 2 diabetes
Background and aims Type 2 diabetes mellitus (DM) is a strong independent risk factor for coronary heart disease. Cyclophilin A (CyPA) is a protein secreted from vascular smooth muscle cells in response to reactive oxygen species. It is suggested that CyPA plays an important role in later stages of...
Main Authors: | Manal M Hussain, Emad A.M. Abdel Hady Mohammed, Alyaa A El-Sherbeny, Amira R Shehata |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2019-01-01
|
Series: | The Egyptian Journal of Internal Medicine |
Subjects: | |
Online Access: | http://www.esim.eg.net/article.asp?issn=1110-7782;year=2019;volume=31;issue=4;spage=416;epage=422;aulast=Hussain |
Similar Items
-
Cyclophilin Inhibitors: An Emerging Class of Therapeutics for the Treatment of Chronic Hepatitis C Infection
by: Philippe Gallay, et al.
Published: (2012-10-01) -
Cyclophilins as Modulators of Viral Replication
by: Stephen D. Frausto, et al.
Published: (2013-07-01) -
Cyclophilins A, B, and C Role in Human T Lymphocytes Upon Inflammatory Conditions
by: Sandra Gegunde, et al.
Published: (2021-03-01) -
Cyclophilin A (CyPA) as a Novel Biomarker for Early Detection of Diabetic Nephropathy in an Animal Model
by: El-Ebidi AM, et al.
Published: (2020-10-01) -
Suppression of Coronavirus Replication by Cyclophilin Inhibitors
by: Takashi Sasaki, et al.
Published: (2013-05-01)